Results 11 to 20 of about 339,316 (310)

Experiences and Support Needs of Caregivers of Patients with Higher-Risk Myelodysplastic Syndrome via Online Bulletin Board in the USA, Canada and UK

Oncology and Therapy, 2023
Introduction Patients with higher-risk myelodysplastic syndromes (MDS) face considerable challenges in disease management and often require caregiver support.
Pauline Frank, Anne Olshan, Tracey Iraca, Cindy Anthony, Sophie Wintrich, Emma Sasse   +5 more
doaj   +1 more source

Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag

Haematologica, 2021
Pretreatment blood counts, particularly an absolute reticulocyte count ≥25×109/L, correlate with response to immunosuppressive therapy in severe aplastic anemia.
Yoshitaka Zaimoku, B. Patel, R. Shalhoub, E. Groarke, Xingmin Feng, Colin O. Wu, N. Young   +6 more
semanticscholar   +1 more source

Diagnostic work‐up for severe aplastic anemia in children: Consensus of the North American Pediatric Aplastic Anemia Consortium

American journal of hematology/oncology, 2021
The North American Pediatric Aplastic Anemia Consortium (NAPAAC) is a group of pediatric hematologist‐oncologists, hematopathologists, and bone marrow transplant physicians from 46 institutions in North America with interest and expertise in aplastic ...
K. Shimano, A. Narla, M. Rose, N. Gloude, S. Allen, Katie Bergstrom, Larisa Broglie, Beth A. Carella, Paul Castillo, Jill L. O. de Jong, Y. Dror, A. Geddis, James N. Huang, B. Lau, C. McGuinn, Taizo A Nakano, K. Overholt, J. Rothman, A. Sharathkumar, E. Shereck, A. Vlachos, T. Olson, A. Bertuch, M. Wlodarski, A. Shimamura, Jessica Boklan   +25 more
semanticscholar   +1 more source

Telomere length of various blood and bone marrow cells in patients with aplastic anemia

Онкогематология, 2023
Background. Aplastic anemia proceeds with bone marrow failure and is associated with immunological suppression of normal blood stem cells’ proliferation, which lead to bone marrow aplasia.
A. V. Luchkin, E. A. Mikhailova, I. V. Galtseva, Z. T. Fidarova, A. V. Abramova, Yu. O. Davydova, N. M. Kapranov, K. A. Nikiforova, S. M. Kulikov, E. N. Parovichnikova   +9 more
doaj   +1 more source

Aplastic Anemia

Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, 2020
Treatments of aplastic anemia are comprised of supportive therapy and aplastic anemia-specific therapy aimed at restoring hematopoiesis. Supportive therapies include transfusion, G-CSF, and the administration of iron chelation agents, as well as dealing ...
Kensuke Usuki
semanticscholar   +1 more source

COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia

Neurology: Neuroimmunology & Neuroinflammation, 2020
Objective To describe a novel case of coronavirus disease 2019 (COVID-19)-associated acute necrotizing encephalopathy (ANE) in a patient with aplastic anemia where there was early brain stem-predominant involvement.
Luke Dixon, J. Varley, A. Gontsarova, D. Mallon, F. Tona, D. Muir, A. Luqmani, I. H. Jenkins, R. Nicholas, B. Jones, A. Everitt   +10 more
semanticscholar   +1 more source

Aplastic Anemia Treated with Eltrombopag during Pregnancy

Case Reports in Obstetrics and Gynecology, 2022
Aplastic anemia is a rare blood disorder characterized by pancytopenia and hypocellular bone marrow. In patients with aplastic anemia, pancytopenia sometimes worsens during pregnancy, and relapse of aplastic anemia in pregnancy is common.
Yuri Suminaga, Yoshitsugu Chigusa, Tadakazu Kondo, Haruko Okamoto, Yosuke Kawamura, Mana Taki, Masaki Mandai, Haruta Mogami   +7 more
doaj   +1 more source

Profil Penderita Anemia Aplastik di RSUP Dr. M. Djamil Padang Tahun 2018-2019

Jurnal Ilmu Kesehatan Indonesia, 2021
Background. Aplastic anemia is a failure of the process of formation and development of blood cells that causes a decrease or absence of hematopoietic precursor cells in the bone marrow.
Amanda Rizki, Zelly Dia Rofinda, Gusti Revilla   +2 more
doaj   +1 more source

Aplastic anemia in China [PDF]

Journal of Translational Internal Medicine, 2018
Abstract Aplastic anemia (AA) is a hematologic disease characterized by pancytopenia. Up to now, severe aplastic anemia (SAA) has been recognized by international and domestic scholars as an autoimmune disease with bone marrow (BM) failure mediated by the hyperfunctional T lymphocytes.
Chunyan Liu, Zonghong Shao
openaire   +3 more sources

Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.

Blood, 2020
Acquired aplastic anemia (AA) and paroxysmal nocturnal hemoglobinuria (PNH) are pathogenically related non-malignant bone marrow failure disorders linked to T-cell mediated autoimmunity and associated with an increased risk of secondary myelodysplastic ...
Lova Sun, D. Babushok
semanticscholar   +1 more source